Registration
 
All news
Top Stories
Editors' Picks
Stocks
Crypto
Economics
Currencies
Commodities
Business & Wealth
Market Voices
Elena Nikulina
Elena Nikulina

Vir Biotechnology strategy shifts to clinic-ready pipeline focus

Vir Biotechnology strategy shifts to clinic-ready pipeline focus
Vir Biotechnology pivots for impact

Vir Biotechnology is directing its efforts toward creating a next-generation pipeline, according to CEO Marianne de Backer.

The shift centers on ensuring that programs entering the clinic will deliver substantial impact, as the company prioritizes projects with strong translational potential. De Backer's leadership and strategy were featured in coverage by the San Francisco Business Times, reflecting Vir Biotechnology's intent to make a significant difference through targeted innovation and clinical advancement.

Vir Biotechnology recently set its Q1 2026 earnings release and investor call for May 6, offering an update on its recent financial performance here. The company’s CEO, Marianne De Backer, also participated in a live fireside chat at the Bank of America Securities 2026 Healthcare Conference here. These engagements follow the firm’s ongoing focus on advancing clinical programs with meaningful impact.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Editor's Picks for You

The end of Bitcoin’s growth era: Why prominent investors doubt its future
  • By Olena Litvinenko
  • 8 hours ago
The end of Bitcoin’s growth era: Why prominent investors doubt its future
Editors' Picks
WeFi CEO: Banks are overstating the threat from stablecoins
  • By Eugene Komchuk
  • 10 hours ago
WeFi CEO: Banks are overstating the threat from stablecoins
Editors' Picks
HSBC’s warning signs point to a bigger risk for global banks
  • By Dmytro Kharkov
  • 12 hours ago
HSBC’s warning signs point to a bigger risk for global banks
Editors' Picks
All Editors' Top Picks

Latest Vir Biotechnology News

Vir Biotechnology advances dual-masked TCE pipeline targeting difficult-to-treat solid tumors
  • By Ksenia Gerey
  • 22.10.2026
Vir Biotechnology advances dual-masked TCE pipeline targeting difficult-to-treat solid tumors
Companies
#Vir Biotechnology
Vir Biotechnology to hold investor call on Q3 2026 performance
  • By Hanna Syniavska
  • 21.10.2026
Vir Biotechnology to hold investor call on Q3 2026 performance
Companies
#Vir Biotechnology
Vir Biotechnology advances Phase 3 ECLIPSE program for Hepatitis Delta treatment
  • By Eugene Komchuk
  • 16.10.2026
Vir Biotechnology advances Phase 3 ECLIPSE program for Hepatitis Delta treatment
Companies
#Vir Biotechnology
All Vir Biotechnology News
  • Olena Litvinenko
  • 8 hours ago
The end of Bitcoin’s growth era: Why prominent investors doubt its future
  • Eugene Komchuk
  • 10 hours ago
WeFi CEO: Banks are overstating the threat from stablecoins
  • Dmytro Kharkov
  • 12 hours ago
HSBC’s warning signs point to a bigger risk for global banks
  • Anastasiia Chabaniuk
  • Yesterday
Why do crypto companies want their own banks?
  • Mikhail Vnuchkov
  • Yesterday
Between record and bubble: How Anthropic is approaching its IPO
  • Elena Nikulina
  • 6 min ago
Altcoins posted major gains within two weeks after last FOMC, Michael van de Poppe notes
  • Mykhailo Ihnatenko
  • 7 min ago
Anthropic trade could be more liquid than SpaceX, Kevin O'Leary notes
  • Alena Volkova
  • 22 min ago
Jordan Kerridge: Google stock falls nearly 9% after Q3 earnings miss
  • Ksenia Gerey
  • 37 min ago
NOW Q3 revenue meets expectations as Q4 guidance issued, Shay Boloor reports
  • Pavlo Kot
  • 52 min ago
Mario Nawfal: Fed keeps rates at 3.75%–4.00% ahead of U.S. midterms
Top News
  • Olga Shendetskaya
  • 5 hours ago
Bank of Canada raises rates for first time in over three years
Bank of Canada raises rates for first time in over three years
  • Eugene Komchuk
  • 6 hours ago
Google develops a Bitcoin custody service
Google develops a Bitcoin custody service
  • Andrey Mastykin
  • 6 hours ago
Oil prices jump amid new threats to Saudi energy infrastructure
Oil prices jump amid new threats to Saudi energy infrastructure
  • Hanna Syniavska
  • 8 hours ago
Nasdaq futures rise as SK Hynix earnings fuel chip rally
Nasdaq futures rise as SK Hynix earnings fuel chip rally
  • Ivan Andriyenko
  • 10 hours ago
Robinhood shares drop 8% as crypto slump weighs on earnings
Robinhood shares drop 8% as crypto slump weighs on earnings
Live News
  • Aleksandra Chaikina
  • Now
DTCC launches securities tokenization service with JPMorgan and Citi
  • Anton Kharitonov
  • Now
EUR/USD remains under pressure near 1.1125 ahead of Fed rate decision
  • Hanna Syniavska
  • Now
Turkey cancels Tera Yatirim license amid $100 billion market rout
  • Mykhailo Ihnatenko
  • Now
AMD stock rebounds as Meta tests Helios systems and Oracle expands EPYC use
  • Mykhailo Ihnatenko
  • Now
Ethereum price prediction: Can $2,300 support prevent another liquidation wave?
Who We Are
Business Solutions
For Users
TU News
Popular Sections
Disclosures
CONTACT US
Legal
We are in Social Media
© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186
  • Risk disclosure:

    Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

    That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.

  • Disclaimer:

    Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

    Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.

  • Disclosure of advertisers and revenues:

    All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

    Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.

onepercentfortheplanet.org https://gdpr.eu/ GDPR World Association of News Publishers